1. Meeting to develop a global consensus on preconception care to reduce maternal and childhood mortality and morbidity. Geneva: WHO, 2012. 67 p. — URL: https://apps.who.int/iris/bitstream/handle/10665/78067/9789241505000_eng.pdf?sequence=1&isAllowed=y.
2. Международное техническое руководство по сексуальному образованию / ЮНЕСКО, Секретариат ЮНЭЙДС, ЮНФПА, ЮНИСЕФ, «ООН-Женщины», ВОЗ. 2018. — URL: https://unesdoc.unesco.org/ark:/48223/pf0000260770_rus.
3. Sexuality education in Europe and Central Asia: state of the art and recent developments. An overview of 25 countries (2018). — URL: https://www.euro.who.int/__data/assets/pdf_file/0010/379054/BZgA_IPPFEN_ComprehensiveStudyReport_Online.pdf.
4. Council of Europe convention on the protection of children against sexual exploitation and sexual abuse/ CETS No. 201. Lanzarote, 25.10.2007. —
URL: https://www.coe.int/ru/web/conventions/full-list/-/conventions/webContent/8616916.
5. Family Planning. A global handbook for providers. Updated 3rd ed. WHO, 2018. — URL: https://apps.who.int/iris/bitstream/handle/10665/260156/9780999203705-eng.pdf;jsessionid=9FCE120789E38CBD7180182E22F8E0E0?sequence=1.
6. Shachar B.Z. et al. Interpregnancy interval and obstetrical complications // Obstet. Gynecol. Surv. 2012. [PMID: 22990461]
7. Радзинский В.Е., Костин И.Н., Князев С.А. Акушерский риск. Максимум информации — минимум опасности для матери и младенца. М.: Эксмо-Пресс, 2009.
8. Радзинский В.Е. Акушерская агрессия, v. 2.0. М.: StatusPraesens, 2017. 870 с.
9. Goodwin J.W., Dunne J.T., Thomas B.W. Antepartum identification of the fetus at risk // Can. Med. Assoc. Jv. 1969. Oct 18. Vol. 101. №8. [PMID: 5348484]
10. Об утверждении инструктивно-методических указаний по организации работы женской консультации: Приказ Минздрава СССР от 22 апреля 1981 года №430.
11. Радзинский В.Е. и др. Женская консультация. М.: ГЭОТАР-медиа, 2020.
12. Bellizzi S. et al. Reasons for discontinuation of contraception among women with a current unintended pregnancy in 36 low and middle-income countries // Contraception. 2020. Jan. [PMID: 31655068]
13. Lassi Z.S. et al. Preconception care: caffeine, smoking, alcohol, drugs and other environmental chemical/radiation exposure // Reprod Health. 2014. Sep 26. [PMID: 25415846]
14. Van Elten T.M. et al. Preconception lifestyle and cardiovascular health in the offspring of overweight and obese women // Nutrients. 2019. Oct. [PMID: 31615021]
15. Legro R.S. et al. Benefit of delayed fertility therapy with preconception weight loss over immediate therapy in obese women with PCOS // J. Clin. Endocrinol. Metab. 2016. Jul. Vol. 101. №7. P. 2658–2666. [PMID: 27172435]
16. Marchi J. et al. Risks associated with obesity in pregnancy, for the mother and baby: a systematic review of reviews // Obes. Rev. 2015. Aug. [PMID: 26016557]
17. Dean S.V. et al. Preconception care: nutritional risks and interventions // Reprod. Health. 2014. Sep 26. [PMID: 25415364]
18. Christian P., Stewart C.P. Maternal micronutrient deficiency, fetal development, and the risk of chronic disease // J. Nutr. 2010. Vol. 140. №3. Р. 437–445. [PMID: 20071652]
19. Ronsmans C., Fisher D.J., Osmond C. et al. Multiple micronutrient supplementation during pregnancy in low-income countries: А meta-analysis of effects on stillbirths and early and late neonatal mortality (The Maternal Micronutrient Supplementation Study Group) // Food and Nutrition Bulletin. 2009. Vol. 30. Suppl. 4. Р. S547–S555. [PMID: 20120796]
20. Gernand A.D., Schulze K.J., Stewart C.P. et al. Micronutrient deficiencies in pregnancy worldwide: health effects and prevention // Nat. Rev. Endocrinol. 2016. Vol. 12. №5. Р. 274–289. [PMID: 27032981]
21. Devakumar D., Fall C.H.D., Sachdev H.S. et al. Maternal antenatal multiple micronutrient supplementation for longterm health benefits in children: a systematic review and meta-analysis // BMC Medicine. 2016. Vol. 14. Р. 90. [PMID: 27306908]
22. Van der Zee B., De Beaufort I.D. Preconception care: a parenting protocol: a moral inquiry into the responsibilities of future parents towards their future children // Bioethics. 2011. Vol. 25. №8. Р. 451–457. [PMID: 21929704]
23. Lassi Z.S. et al. Preconception care: preventing and treating infections // Reprod. Health. 2014. Sep 26. [PMID: 25415557]
24. Lassi Z.S. et al. Preconception care: screening and management of chronic disease and promoting psychological health // Reprod. Health. 2014. Sep 26. [PMID: 25415675]
25. Blom K. et al. Pregnancy and Glomerular Disease: A Systematic Review of the Literature with Management Guidelines // Clin. J. Am. Soc. Nephrol. 2017. Nov 7. [PMID: 28522651]
26. Гречанина Е.Я., Лесовой В.Н., Мясоедов В.В. и др. Закономерная связь между развитием некоторых эпигенетических заболеваний и нарушением метилирования ДНК вследствие дефицита ферментов фолатного цикла // Ультразвуковая перинатальная диагностика. 2010. №29. С. 27–59.
27. Dean S.V., Imam A.M., Lassi Z.S. et al. Importance of intervening in the preconception period to impact pregnancy outcomes // Nestle Nutr. Inst. Workshop Ser. 2013. Vol. 74. Р. 63–73. [PMID: 23887104]
28. Dean S.V., Lassi Z.S., Imam A.M. et al. Preconception care: closing the gap in the continuum of care to accelerate improvements in maternal, newborn and child health // Reprod. Health. 2014. Vol. 11. Suppl. 3. Р. S1. [PMID: 25414942]
29. Wilson R.D. et al. Pre-conception Folic Acid and Multivitamin Supplementation for the Primary and Secondary Prevention of Neural Tube Defects and Other Folic Acid-Sensitive Congenital Anomalies // J. Obstet. Gynaecol. Can. 2015. Vol. 37. №6. Р. 534–352. [PMID: 26334606]
30. Meeting to develop a global consensus on preconception care to reduce maternal and childhood mortality and morbidity. Geneva: World Health Organization, 2013. — URL: http://apps.who.int/iris/handle/10665/78067.
31. Liu L. et al. Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000 // Lancet. 2012. Vol. 379. Р. 2151–2161. [PMID: 22579125]
32. Draft action plan for the prevention and control of noncommunicable diseases 2013–2020. Geneva: World Health Organization, 2013. — URL: http://www.who.int/nmh/events/ncd_action_plan/en/.
33. Robbins C.L., Zapata L.B., Farr S.L. et al. Core state preconception health indicators — pregnancy risk assessment monitoring system and behavioral risk factor surveillance system, 2009 // MMWR Surveill. Summ. 2014. Vol. 63. №3. Р. 1–62. [PMID: 24759729]
34. Chen I., Jhangri G.S., Lacasse M et al. Relationship Between Interpregnancy Interval and Adverse Perinatal and Neonatal Outcomes in Northern Alberta // J. Obstet. Gynaecol. Can. 2015. Vol. 37. №7. P. 598–605. [PMID: 26366816]
35. Conde-Agudelo A. et al. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis // JAMA. 2006. Apr 19. Vol. 295. №15. P. 1809–1823. [PMID: 16622143]
36. Conde-Agudelo A. et al. Effect of the interpregnancy interval on perinatal outcomes in Latin America // Obstet. Gynecol. 2005. Aug. Vol. 106. №2. P. 359–366. [PMID: 16055588]
37. Emily A DeFranco E.A. et al. Influence of interpregnancy interval on neonatal morbidity // Am J Obstet Gynecol. 2015. Mar. Vol. 212. №3. P. 386.e1–9. [Epub 2014 Nov 15] [PMID: 25460837]
38. Zhu B.P. Effect of interpregnancy interval on birth outcomes: findings from three recent US studies // Int. J. Gynaecol. Obstet. 2005. Apr. Vol. 89. Suppl. 1. P. S25–33. [PMID: 15820365]
39. Infant and young child feeding. 2020. — URL: https://www.who.int/en/news-room/fact-sheets/detail/infant-and-young-child-feeding.
40. Rodrigues T., Barros H. Short interpregnancy interval and risk of spontaneous preterm delivery // Eur. J. Obstet. Gynecol. Reprod. Biol. 2008. Feb. [PMID: 17490802]
41. Conde-Agudelo A. et al. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis // JAMA. 2006. Apr 19. Vol. 295. №15. P. 1809–1823. [PMID: 16622143]
42. De Weger F.J. et al. Advanced maternal age, short interpregnancy interval, and perinatal outcome // Am. J. Obstet. Gynecol. 2011. May. Vol. 204. №5. P. 421.e1–9. [Epub 2011 Feb 2] [PMID: 21288503]
43. Salihu H.M. et al. The impact of birth spacing on subsequent feto-infant outcomes among community enrollees of a federal healthy start project // J. Community Health. 2012. Feb. Vol. 37. №1. P. 137–142. [PMID: 21656254]
44. Conde-Agudelo A., Belizán J.M. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study // BMJ. 2000. Nov 18. [PMID: 11082085]
45. Darios Getahun D. et al. Previous cesarean delivery and risks of placenta previa and placental abruption // Obstet. Gynecol. 2006. Apr. [PMID: 16582111]
46. Blumenfeld Y.J. et al. Association between maternal characteristics, abnormal serum aneuploidy analytes, and placental abruption // Am. J. Obstet. Gynecol. 2014. Aug. [PMID: 24631707]
47. Conde-Agudelo A. et al. Effects of birth spacing on maternal health: a systematic review // Am. J. Obstet. Gynecol. 2007. Apr. Vol. 196. №4. P. 297–308. [PMID: 17403398]
48. A Conde-Agudelo A., Belizán J.M. Maternal morbidity and mortality associated with interpregnancy interval: cross sectional study// BMJ. 2000. Nov 18. [PMID: 11082085]
49. Cheslack-Postava K. et al. Closely spaced pregnancies are associated with increased odds of autism in California sibling births // Pediatrics. 2011. Feb. Vol. 127. №2. P. 246–253. [Epub 2011 Jan 10] [PMID: 21220394]
50. Gunawardana L. et al. Pre-conception inter-pregnancy interval and risk of schizophrenia // Br. J. Psychiatry. 2011. Oct. Vol. 199. №4. P. 338–339. [Epub 2011 Aug 4] [PMID: 21816866]
51. Conde-Agudelo A. et al. Birth spacing and risk of adverse perinatal outcomes: a meta-analysis // JAMA. 2006. Apr 19. Vol. 295. №15. P. 1809–1823. [PMID: 16622143]
52. Regan A.K. et al. A population-based matched-sibling analysis estimating the associations between first interpregnancy interval and birth outcomes // Am. J. Epidemiol. 2019. Jan 1. [PMID: 30188970]
53. DeFranco E.A. et al. Influence of interpregnancy interval on neonatal morbidity // Am. J. Obstet. Gynecol. 2015. Mar. Vol. 212. №3. P. 386.e1–9. [Epub 2014 Nov 15] [PMID: 25460837]
54. McKinney D. et al. The influence of interpregnancy interval on infant mortality // Am. J. Obstet. Gynecol. 2017. Mar. Vol. 216. №3. P. 316.e1–316.e9. [Epub 2016 Dec 27] [PMID: 28034653]
55. Getahun D. et al. Recurrence of preterm premature rupture of membranes in relation to interval between pregnancies // Am. J. Obstet. Gynecol. 2010. Jun. Vol. 202. №6. P. 570.e1–6. [Epub 2010 Feb 4] [PMID: 20132922]
56. Chen I. et al. Relationship between interpregnancy interval and congenital anomalies // Am. J. Obstet. Gynecol. 2014. Jun. Vol. 210. №6. P. 564.e1–8. [Epub 2014 Feb 6] [PMID: 24508646]
57. Skjaerven R. et al. The interval between pregnancies and the risk of preeclampsia // N. Engl. J. Med. 2002. Jan 3. Vol. 346. №1. P. 33–38. [PMID: 11778000]
58. Mostello D. et al. Preeclampsia in the parous woman: who is at risk? // Am. J. Obstet. Gynecol. 2002. Aug. Vol. 187. №2. P. 425–459. [PMID: 12193937]
59. Zhu B.-P. et al. Labor dystocia and its association with interpregnancy interval // Am. J. Obstet. Gynecol. 2006. Jul. Vol. 195. №1. P. 121–128. [Epub 2006 Apr 25] [PMID: 16635468]
60. DeFranco E.A. et al. Influence of interpregnancy interval on neonatal morbidity // Am. J. Obstet. Gynecol. 2015. Mar. Vol. 212. №3. P. 386.e1–9. [Epub 2014 Nov 15] [PMID: 25460837]
61. Trogstad L.I. et al. Changing paternity and time since last pregnancy; the impact on pre-eclampsia risk. A study of 547 238 women with and without previous pre-eclampsia // Int. J. Epidemiol. 2001. Dec. Vol. 30. №6. P. 1317–1322. [PMID: 11821338]
62. Rodrigues T., Barros H. Short interpregnancy interval and risk of spontaneous preterm delivery // Eur. J. Obstet. Gynecol. Reprod. Biol. 2008. Feb. Vol. 136. №2. P. 184–188. [Epub 2007 May 9] [PMID: 17490802]
63. Ye L. et al. Systematic review of the effects of birth spacing after cesarean delivery on maternal and perinatal outcomes // Int. J. Gynaecol. Obstet. 2019. Oct. Vol. 147. №1. P. 19–28. [Epub 2019 Jul 9] [PMID: 31233214]
64. Quinn M.M. et al. Interpregnancy interval and singleton live birth outcomes from in vitro fertilization // Obstet. Gynecol. 2018. Jul. Vol. 132. №1. P. 115–121. [PMID: 29889753]
65. Ciancimino L., Laganà A.S., Chiofalo B. et al. Would it be too late? A retrospective case-control analysis to evaluate maternal-fetal outcomes in advanced maternal age // Arch. Gynecol. Obstet. 2014. Vol. 290. №6. Р. 1109–1114. [PMID: 25027820]
66. Geller S.E., Cox S.M., Callaghan W.M. et al. Morbidity and mortality in pregnancy: Laying the ground work for safe motherhood // Womens Health Issues. 2006. Vol. 16. Р. 176. [PMID: 16920522]
67. Schummers L. Association of short interpregnancy interval with pregnancy outcomes according to maternal age // JAMA Intern Med. 2018. Dec 1. Vol. 178. №12. P. 1661–1670. [PMID: 30383085]
68. Kangatharan C., Labram S., Bhattacharya S. Interpregnancy interval following miscarriage and adverse pregnancy outcomes: systematic review and meta-analysis // Hum. Reprod. Update. 2017. Mar 1. Vol. 23. №2. P. 221–231. [PMID: 27864302]
69. Gong X. et al. Pregnancy loss and anxiety and depression during subsequent pregnancies: data from the C-ABC study // Eur. J. Obstet. Gynecol. Reprod. Biol. 2013. Jan. Vol. 166. №1. P. 30–36. [Epub 2012 Nov 10] [PMID: 23146315]
70. DaVanzo J. et al. Effects of interpregnancy interval and outcome of the preceding pregnancy on pregnancy outcomes in Matlab, Bangladesh // BJOG. 2007. Sep. Vol. 114. №9. P. 1079–1087. [Epub 2007 Jul 6] [PMID: 17617195]
71. Regan A.K. et al. Association between interpregnancy interval and adverse birth outcomes in women with a previous stillbirth: an international cohort study // Lancet. 2019. Apr 13. Vol. 393. №10180. P. 1527–1535. [Epub 2019 Feb 28] [PMID: 30827781]
72. RCOG: Best practice in postpartum family planning. Best Practice Paper №1. 2015. 13 р. — URL: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/bpp1/.
73. Медицинские критерии приемлемости для использования методов контрацепции. 5-е изд. ВОЗ, 2017. — URL: https://www.euro.who.int/__data/assets/pdf_file/0005/348116/MEC-merged.pdf?ua=1.
74. Contraceptive eligibility for women at high risk of HIV. World Health Organization, 2019. — URL: https://apps.who.int/iris/bitstream/handle/10665/326653/9789241550574-eng.pdf?ua=1.
75. Berens P., Labbok M. ABM clinical protocol №13: contraception during breastfeeding, Revised 2015 // Breastfeed Med. 2015. Vol. 10. №1. P. 3–12. [PMID: 25551519]
76. Thiel de Bocanegra H., Chang R., Howell M. et al. Interpregnancy intervals: impact of postpartum contraceptive effectiveness and coverage // Am. J. Obstet. Gynecol. 2014. Vol. 210. №4. Р. 311.e1. [PMID: 24334205]
77. Baş E.K. et al. Maternal Characteristics and Obstetric and Neonatal Outcomes of Singleton Pregnancies Among Adolescents // Med Sci Monit . 2020. Feb 22. Vol. 26. P. e919922. [PMID: 32087083]
78. Schimmel M.S. et al. The effects of maternal age and parity on maternal and neonatal outcome // Arch. Gynecol. Obstet. 2015. Apr. Vol. 291. №4. P. 793–798. [Epub 2014 Sep 17] [PMID: 25227657]
1. Об основах охраны здоровья граждан в Российской Федерации: Федеральный закон от 21 ноября 2011 года №323-ФЗ.
2. Об утверждении порядка оказания медицинской помощи по профилю «акушерство и гинекология»: Проект приказа Минздрава России. — URL: https://regulation.gov.ru/projects#departments=11&StartDate=3.8.2020&EndDate=3.8.2020&npa=106754.
3. Об утверждении Положения об организации оказания первичной медико-санитарной помощи взрослому населению: Приказ Минздравсоцразвития России от 15 мая 2012 года №543н.
4. Об утверждении Правил предоставления медицинскими организациями платных медицинских услуг: Постановление Правительства РФ от 4 октября 2012 года №1006.
5. Berghella V. Obstetric Evidence Based Guidelines 3rd edition. CRC Press, 2017. P. 1–11.
6. ACOG Committee Opinion No. 762: Prepregnancy Counseling // Obstet. Gynecol. 2019. Jan. Vol. 133. №1. P. e78–e89. [PMID: 30575679]
7. Jack B.W., Culpepper L., Babcock J. et al. Addressing preconception risks identified at the time of a negative pregnancy test: a randomized trial // J. Fam. Pract. 1998. Vol. 47. Р. 33–38. [PMID: 9673606]
8. Adepu R., Swam M.K. Development and evaluation of patient information leaflets (PIL) usefulness // Ind. J. Pharm. Scien. 2012. Vol. 74. №2. Р. 174–178. [PMID: 23326002]
9. Shahidi S., Aghdak P., Farajzadegan Z. et al. Reviewing the effectiveness of pre-pregnancy counseling protocol on pregnancy and labor indices // Iranian Journal of Nursing and Midwifery Research. 2011. Vol. 16. №4. Р. 265–272. [PMID: 23450844]
10. Young A. et al. What do patients want? Tailoring medicines information to meet patients’ needs // Res. Social. Adm. Pharm. 2017. Nov. Vol. 13. №6. P. 1186–1190. [Epub 2016 Oct 26] [PMID: 27818214]
11. Body mass index — BMI. WHO. — URL: https://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi.
12. Waist Circumference and Waist–Hip Ratio: Report of a WHO Expert Consultation Geneva, 8–11 December 2008. — URL: https://apps.who.int/iris/bitstream/handle/10665/44583/9789241501491_eng.pdf?ua=1.
13. Артериальная гипертония у беременных: Клинические рекомендации. М., 2016.
14. Об утверждении порядка проведения профилактического медицинского осмотра и диспансеризации определённых групп взрослого населения: Приказ Минздрава России от 13 марта 2019 года №124н.
15. Соловьёва А.В. Анемии и репродуктивное здоровье. М.: Медиабюро Статус Презенс, 2019.
16. Hogeveen M., Blom H.J., den Heijer M. Maternal homocysteine and small-for-gestational-age offspring: systematic review and meta-analysis // Am. J. Clin. Nutr. 2012. Vol. 95. Р. 130–136. [PMID: 22170376]
17. Vollset S.E., Refsum H., Irgens L.M. et al. Plasma total homocysteine, pregnancy complications, and adverse pregnancy outcomes: the Hordaland Homocysteine study // Am. J. Clin. Nutr. 2000. Vol. 71. Р. 962–968. [PMID: 10731504]
18. Harvey N.C., Holroyd C., Ntani G. et al. Vitamin D supplementation in pregnancy: А systematic review // Health Technol Assess. 2014. Vol. 18. №45. Р. 1–190. [PMID: 25025896]
19. Johnson D.D. et al. Vitamin D deficiency and insufficiency is common during pregnancy // Am. J. Perinatol. 2011. Vol. 28. №1. С. 7–12. [PMID: 20640974]
20. Lassi Z.S. et al. Preconception care: caffeine, smoking, alcohol, drugs and other environmental chemical/radiation exposure // Reprod Health. 2014. Sep 26. Vol. 11. Suppl. 3. P. S6. [Epub 2014 Sep 26] [PMID: 25415846]
21. Association of state and territorial health officials: Smoking cessation strategies for women before, during, and after pregnancy recommendations for state and territorial health agencies. 2013. 16 р. — URL: http://www.astho.org/programs/prevention/tobacco/.
22. Smoking cessation during pregnancy a clinician’s guide to helping pregnant women quit smoking. Self-instructional guide and tool kit: An Educational Program from the ACOG. 2011. 19 р.
23. Rosenblum E.R., Stauber R.E., Van Thiel D.H. et al. Assessment of the estrogenic activity of phytoestrogens isolated from bourbon and beer // Alcohol. Clin. Exp. Res. 1993. Vol. 17. №6. Р. 1207–1209. [PMID: 8116832]
24. Gavaler J.S. Alcoholic beverages as a source of estrogens // Alcohol Health Res World. 1998. Vol. 22. №3. Р. 220–227. [PMID: 15706799]
25. Brandenberger G., Weibel L. The 24-h growth hormone rhythm in men: sleep and circadian influences questioned // J. Sleep Res. 2004. Vol. 13. №3. P. 251–255. [PMID:15339260]
26. Hegaard H.K., Hedegaard M., Damm P. et al. Leisure time physical activity is associated with a reduced risk of preterm delivery // Am. J. Obstet. Gynecol. 2008. Vol. 198. Р. 180. [PMID: 18226619]
27. Беременность ранних сроков. От прегравидарной подготовки к здоровой гестации / Под ред. В.Е. Радзинского, А.А. Оразмурадова. 3-е изд., испр. и доп. М.: Редакция журнала StatusPraesens, 2020. 798 с.
28. Obesity in Pregnancy. Practice Bulletin №156 ACOG. 2015. — URL: https://www.acog.org/clinical/clinical-guidance/practice-bulletin/articles/2015/12/obesity-in-pregnancy.
29. Yuan X. et al. Association between prepregnancy body mass index and risk of congenital heart defects in offspring: an ambispective observational study in China // BMC Pregnancy Childbirth. 2020. Aug 4. Vol. 20. №1. P. 444. [PMID: 32753039]
30. Falzone N., Huyser C., Becker P. et al. The effect of pulsed 900-MHz GSM mobile phone radiation on the acrosome reaction, head morphometry and zona binding of human spermatozoa // Int. J. Androl. 2011. Vol. 34. №1. P. 20–26 [PMID: 20236367]
31. Levitas E. et al. Relationship between the duration of sexual abstinence and semen quality: analysis of 9,489 semen samples // Fertil. Steril. [Internet]. 2005. Vol. 83. №6. P. 1680–1686.
32. Elzanaty S., Malm J., Giwercman A. Duration of sexual abstinence: epididymal and accessory sex gland secretions and their relationship to sperm motility // Hum Reprod [Internet]. 2005. Vol. 20. №1. P. 221–225.
33. Об утверждении национального календаря профилактических прививок и календаря профилактических прививок по эпидемическим показаниям: Приказ Минздрава России от 21 марта 2014 года №125н.
34. Ami N., Bernstein M., Boucher F. et al. Folate and neural tube defects: The role of supplements and food fortification // Paediatr. Child Health. 2016. Vol. 21. №3. P. 145–154. [PMID: 27398055]
35. Lumley J. et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects // Cochrane Database of Systematic Reviews. 2007. Iss. 4. Art. №CD001056. [PMID: 21491380]
36. Williams P.J., Bulmer J.N., Innes B.A., Pipkin F. Possible roles for folic acid in the regulation of trophoblast invasion and placental development in normal early human pregnancy // Biol. Reprod. 2011. Vol. 84. Р. 1148–1153. [PMID: 21349824]
37. Kim M.W., Hong S.C., Choi J.S. et al. Homocysteine, folate and pregnancy outcomes // J. Obstet. Gynaecol. 2012. Vol. 32. №6. Р. 520–524. [PMID: 22779952]
38. Czeizel A.E., Puho E.H., Langmar Z. et al. Possible association of folic acid supplementation during pregnancy with reduction of preterm birth: a population-based study // Eur. J. Obstet. Gynecol. Reprod. Biol. 2010. Vol. 148. Р. 135–140. [PMID: 19926391]
39. Brown A.S., Bottiglieri T., Schaefer C.A. et al. Elevated prenatal homocysteine levels as a risk factor for schizophrenia // Arch. Gen. Psychiatry. 2007. Vol. 64. №1. P. 31–39. [PMID: 17199052]
40. Susser E.S.E., Schaefer C.A., Brown A.S. et al. The design of the prenatal determinants of schizophrenia study // Schizophr. Bull. 2000. Vol. 26. P. 257–273. [PMID: 10885629]
41. Young S.S., Eskenazi B., Marchetti F.M. et al. The association of folate, zinc and antioxidant intake with sperm aneuploidy in healthy non-smoking men // Hum. Reprod. 2008. Vol. 23. №5. P. 1014–1022. [PMID: 18353905.]
42. Best practice in maternal-fetal medicine. FIGO Working Group on Best Practice in Maternal-Fetal Medicine // Int. J. Gynecol. Obstet. 2015. Vol. 128. P. 80–82. [PMID: 25481030]
43. Periconceptional folic acid supplementation to prevent neural tube defects. — URL: https://www.who.int/elena/titles/folate_periconceptional/en/.
44. De‐Regil L.M. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Systematic Review. 2015. — URL: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007950.pub3/full.
45. Brämswig S., Prinz-Langenohl R., Lamers Y. et al. Supplementation with a multivitamin containing 800 microg of folic acid shortens the time to reach the preventive red blood cell folate concentration in healthy women // Int. J. Vitam. Nutr. Res. 2009. Vol. 79. Р. 61–70. [PMID: 20108207]
46. Hanson M.A. et al. The International Federation of Gynecology and Obstetrics (FIGO) recommendations on adolescent, preconception, and maternal nutrition: «Think Nutrition First» // Int. J. Gynaecol. Obstet. 2015. Oct. Vol. 131. Suppl. 4. P. S213–253. [PMID: 26433230]
47. Wang M. et al. Maternal body mass index and the association between folic acid supplements and neural tube defects // Acta Paediatr. 2013. Vol. 102. №9. P. 908–913.
48. Blumer I. et al. Diabetes and pregnancy: an endocrine society clinical practice guideline. // J Clin Endocrinol Metab. 2013. Vol. 98. №11. P. 4227–4249.
49. Greenberg J.A. et al. Folic Acid Supplementation and Pregnancy: More Than Just Neural Tube Defect Prevention // Rev. Obstet. Gynecol. Summer. 2011. Vol. 4. №2. P. 52–59. [PMID: 22102928]
50. Bayes J. et al. The Bioavailability of Various Oral Forms of Folate Supplementation in Healthy Populations and Animal Models: A Systematic Review // J. Altern. Complement. Med. 2019. Feb. Vol. 25. №2. P. 169–180. [Epub 2018 Jul 16] [PMID: 30010385]
51. Guideline: Daily iron supplementation in adult women and adolescent girls. Geneva: WHO. — URL: https://apps.who.int/iris/bitstream/handle/10665/
204761/9789241510196_eng.pdf?sequence=1/
52. Intermittent iron and folic acid supplementation in menstruating women. WHO. — URL: https://www.who.int/elena/titles/guidance_summaries/iron_women/en/.
53. Harding K.B. et al. Iodine supplementation for women during the preconception, pregnancy and postpartum period // Cochrane Database Syst. Rev. 2017. Mar 5. Vol. 3. Iss. 3. Art. №CD011761. [PMID: 28260263]
54. WHO. Iodine supplementation in pregnant and lactating women. Geneva: World Health Organization; 2016. — URL: https://www.who.int/elena/titles/iodine_pregnancy/en/.
55. De-Regil L.M. et al. Iodine supplementation for women during the preconception, pregnancy and postpartum period // Protocol. Cochrane Database of Systematic Reviews. 2015.
56. Cobra C. et al. Infant survival is improved by oral iodine supplementation // Journal of Nutrition. 1997. Vol. 127. P. 574–578.
57. Zimmermann M.B. The effects of iodine deficiency in pregnancy and infancy // Paediatric and Perinatal Epidemiology. 2012. Vol. 26. Suppl. 1. P. 108–117.
58. Rosen C.J. et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement // Endocr. Rev. 2012. Vol. 33. №3. P. 456–492. [PMID: 22596255]
59. Lucas R.M. et al. Future health implications of prenatal and early-life vitamin D status // Nutr. Rev. 2008. Vol. 66. №12. P. 710–720. [PMID: 19019040]
60. Institute of Medicine (US) Standing Committee on the Scientific Evaluationof Dietary Reference Intakes. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, D.C., USA:The National Academies Press, 1997.
61. Leffelaar E.R. et al. Maternal early pregnancy vitamin D status in relation to fetal and neonatal growth: results of the multiethnic Amsterdam Born Children and their Development cohort // Br. J. Nutr. 2010. Vol. 104. №1. P. 108–117. [PMID: 20193097]
62. Gernand A.D. et al. Maternal Serum 25-Hydroxyvitamin D and Measures of Newborn and Placental Weight in a U.S. Multicenter Cohort Study // J. Clin. Endocrinol. Metab. 2013. Vol. 98. №1. P. 398–404 [PMID: 23162094]
63. Междисциплинарное руководство по профилактике и лечению дефицита витамина D в прегравидарном периоде, во время беременности и после родов. М., 2020.
64. Мейя Л., Резеберга Д. Надлежащее питание при планировании беременности и во время беременности — основа здорового начала жизни: Рекомендации для специалистов в области здравоохранения. Европейское бюро ВОЗ, 2016. — URL: https://www.euro.who.int/__data/assets/pdf_file/0011/337565/Latvia-nutrition-during-pregnancy_RUS-with-cover.pdf.
65. Robert M. Greenhagen R.A. et al. Serum vitamin D and diabetic foot complications // Diabet Foot Ankle. 2019. Vol. 10. №1. P. 1579631. [PMID: 30815231]
66. Mumford S.L., Chavarro J.E., Zhang C. et al. Dietary fat intake and reproductive hormone concentrations and ovulation in regularly menstruating women // Am. J. Clin. Nutr. 2016. Vol. 103. №3. P. 868–877. [PMID: 26843151]
67. Stanhiser J. et al. Omega-3 fatty acid supplementation and fecundability // Fertility and Sterility. 2019. Vol. 3. P. e28.
68. Bakouei F. et al. Efficacy of n-3 fatty acids supplementation on the prevention of pregnancy induced-hypertension or preeclampsia: A systematic review and meta-analysis // Taiwan J. Obstet. Gynecol. 2020. Jan. Vol. 59. №1. P. 8–15. [PMID: 32039806]
69. Innis S.M. Fatty acids and early human development // Early Hum. Dev. 2007. Vol. 83. №12. Р. 761–766. [PMID: 17920214]
70. Calder P.C. The relationship between the fatty acid composition of immune cells and their function // Prostaglandins Leukot. Essent. Fatty Acids. 2008. Vol. 79. №3–5. Р. 101–108. [PMID: 18951005]
71. Jack B.W., Atrash H., Coonrod D.V. et al. The clinical content of preconception care: an overview and preparation of this supplement // Am. J. Obstet. Gynecol. 2008. Vol. 199. №6. Suppl. 2. Р. s266–s279. [PMID: 19081421]
72. Hibbeln J.R., Davis J.M., Steer C. et al. Maternal seafood consumption in pregnancy and neurodevelopmental outcomes in childhood (ALSPAC study): An observation cohort study // Lancet. 2007. Vol. 369. Р. 578. [PMID: 17307104]
73. Middleton P. et al. Omega-3 fatty acid addition during pregnancy // Cochrane Database Syst. Rev. 2018. [PMID: 30480773]
74. Рекомендуемые уровни потребления пищевых и биологически активных веществ: Методические рекомендации МР 2.3.1.1915-04 (утв. Федеральной службой по надзору в сфере защиты прав потребителей и благополучия человека 2 апреля 2004 года).
75. Leitich H., Bodner-Adler B., Brunbaure M. et al. Bacterial vaginosis as a risk factor for preterm delivery: a meta-analysis // Am. J. Obstet. Gynecol. 2003. Vol. 189. P. 139–147. [PMID: 12861153]
76. Leitich H., Kiss H. Asymptomatic bacterial vaginosis and intermediate flora as risk factors for adverse pregnancy outcome // Best Pract. Res. Clin. Obstet. Gynaecol. 2007 Jun. Vol. 21. №3. P. 375–390. Epub 2007 Jan 22] [PMID: 17241817][
77. Bothuyne-Queste E. et al. Is the bacterial vaginosis risk factor of prematurity? Study of a cohort of 1336 patients in the hospital of Arras // J. Gynecol. Obstet. Biol. Reprod. 2012. Vol. 41. №3. Р. 262–270. [PMID: 22377639]
78. Hillier S.L. et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. The Vaginal Infections and Prematurity Study Group // N. Engl. J. Med. 1995. Dec 28. Vol. 333. №26. P. 1737–1742. [PMID: 7491137]
79. Kahwati L.C. et al. Screening for Bacterial Vaginosis in Pregnant Adolescents and Women to Prevent Preterm Delivery: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force // JAMA. 2020. Apr 7. Vol. 323. №13. P. 1293–1309. [PMID: 32259235]
80. Owens D.K. et al. Screening for Bacterial Vaginosis in Pregnant Persons to Prevent Preterm Delivery: US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force // JAMA. 2020. Apr 7. Vol. 323. №13. P. 1286–1292. [PMID: 32259236]
81. Van Oostrum N. et al. Risks associated with bacterial vaginosis in infertility patients: a systematic review and meta-analysis // Hum Reprod. 2013. Jul. 28. №7. P. 1809–1815. [Epub 2013 Mar 29] [PMID: 23543384]
1. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. М., 2019. С. 57.
2. Sherrard J., Wilson J., Donders G. et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge // Int. J. STD AIDS. 2018. Vol. 29. №13. P. 1258–1272.
3. Diseases characterized by vaginal discharge: 2015 sexually transmitted diseases treatment guidelines. — URL: https://www.cdc.gov/std/ tg2015/vaginal-discharge.htm.
4. Sherrard J., Wilson J., Donders G. et al. 2018 European (IUSTI/WHO) International Union against sexually transmitted infections (IUSTI) World Health Organisation (WHO) guideline on the management of vaginal discharge // Int. J. STD AIDS. 2018. Vol. 29. №13. P. 1258–1272. [PMID: 30049258]
5. Han C., Li H., Han L. et al. Aerobic vaginitis in late pregnancy and outcomes of pregnancy // Eur. J. Clin. Microbiol. Infect Dis. 2019. Vol. 38. №2. P. 233–239. [PMID: 30467614]
6. Hočevar K., Maver A., Vidmar Šimic M. et al. Vaginal Microbiome Signature Is Associated With Spontaneous Preterm Delivery // Front Med (Lausanne). 2019. Vol. 6. P. 201. [PMID: 31552254]
7. Gillet E., Meys J.F., Verstraelen H. et al. Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis // BMC Infect Dis. 2011. [PMID: 21223574]
8. Haggerty C.L., Totten P.A., Tang G. et al. Identification of novel microbes associated with pelvic inflammatory disease and infertility // Sex Transm Infect. 2016. Vol. 92. №6. P. 441–446. [PMID: 26825087]
9. Shipitsyna E., Khusnutdinova T., Budilovskaya O. et al. Bacterial vaginosis-associated vaginal microbiota is an age-independent risk factor for Chlamydia trachomatis, Mycoplasma genitalium and Trichomonas vaginalis infections in low-risk women, St. Petersburg, Russia // Eur. J. Clin. Microbiol. Infect Dis. 2020. Vol. 39. №7. P. 1221–1230. [PMID: 32036466]
10. Подзолкова Н.М., Никитина Т.И. Новые возможности терапии рецидивирующих вульвовагинальных инфекций: анализ и обсуждение результатов многоцентрового исследования БИОС-2 // Акуш. и гинекол. 2014. №4. С. 68–74.
11. Радзинский В.Е., Хамошина М.Б., Оразов М.Р. и др. Двухэтапная терапия при остром вагините: результаты российского многоцентрового наблюдательного исследования «ДеФиле» // StatusPraesens. Гинекология, акушерство, бесплодный брак. 2019. №5 (61). С. 51–54.
12. Amaya-Guio J., Viveros-Carreño D.A., Sierra-Barrios E.M. et al. Antibiotic treatment for the sexual partners of women with bacterial vaginosis // Cochrane Database Syst. Rev. 2016. Vol. 10. Iss. 10. Art. №CD011701. [PMID: 27696372]
13. Güdücü N., Gönenç G., Işçi H. et al. Clinical importance of detection of bacterial vaginosis, trichomonas vaginalis, candida albicans and actinomyces in Papanicolaou smears // Clin. Exp. Obstet. Gynecol. 2012. Vol. 39. №3. P. 333–336. [PMID: 23157037]
14. Pramanick R., Mayadeo N., Warke H. et al. Vaginal microbiota of asymptomatic bacterial vaginosis and vulvovaginal candidiasis: Are they different from normal microbiota? // Microb. Pathog. 2019. Vol. 134. P. 103599. [PMID: 31212037]
15. Crouss T., Sobel J.D., Smith K., Nyirjesy P. Long-Term Outcomes of Women With Recurrent Vulvovaginal Candidiasis After a Course of Maintenance Antifungal Therapy // J. Low. Genit. Tract. Dis. 2018. Vol. 22. №4. P. 382–386. [PMID: 29975334]
16. Maraki S., Mavromanolaki V.E., Stafylaki D. et al. Epidemiology and antifungal susceptibility patterns of Candida isolates from Greek women with vulvovaginal candidiasis // Mycoses. 2019. Vol. 62. №8. P. 692–697. [PMID: 31132175]
17. Hassan M.F., Rund N.M.A., El-Tohamy O. et al. Does Aerobic Vaginitis Have Adverse Pregnancy Outcomes? Prospective Observational Study // Infect Dis Obstet. Gynecol. 2020. Vol. 2020. P. 5842150. [PMID: 32395067]
18. Ghosh A.P., Aycock C., Schwebke J.R. In Vitro Study of the Susceptibility of Clinical Isolates of Trichomonas vaginalis to Metronidazole and Secnidazole // Antimicrob Agents Chemother. 2018. Vol. 62. №4. P. e02329 17. [PMID: 29439963]
19. 2017 European guideline for the management of pelvic inflammatory disease. — URL: http://www.fasgo.org.ar/images/2017_European_guideline_for_the_management_of_pelvic_inflammatory_disease.pdfю.
20. Pelvic Inflammatory Disease (PID). — URL: https://www.cdc.gov/std/tg2015/pid.htm.
21. ACOG. Pelvic Inflammatory Disease (PID). — URL: https://www.acog.org/store/products/patient-education/pamphlets/gynecologic-problems/pelvic-inflammatory-disease.
22. Trent M., Bass D., Ness R.B., Haggerty C. Recurrent PID, subsequent STI, and reproductive health outcomes: findings from the PID evaluation and clinical health (PEACH) study // Sex Transm. Dis. 2011. Vol. 38. №9. P. 879–881. [PMID: 21844746]
23. Ah-Kit X., Hoarau L., Graesslin O., Brun J.L. Suivi et conseils après infection génitale haute. RPC infections génitales hautes CNGOF et SPILF [Follow-up and counselling after pelvic inflammatory disease: CNGOF and SPILF Pelvic Inflammatory Diseases Guidelines // Gynecol. Obstet. Fertil. Senol. 2019. Vol. 47. №5. P. 458–464. [PMID: 30878686]
24. Herzog S.A., Heijne J.C., Althaus C.L., Low N. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies // Sex Transm. Dis. 2012. Vol. 39. №8. P. 628–637. [PMID: 22801346]
25. Cina M., Baumann L., Egli-Gany D. et al. Mycoplasma genitalium incidence, persistence, concordance between partners and progression: systematic review and meta-analysis // Sex Transm. Infect. 2019. Vol. 95. №5. P. 328–335. [PMID: 31055469]
26. Savaris R.F., Fuhrich D.G., Duarte R.V. et al. Antibiotic therapy for pelvic inflammatory disease: an abridged version of a Cochrane systematic review and meta-analysis of randomised controlled trials // Sex Transm. Infect. 2019. Vol. 95. №1. P. 21–27. [PMID: 30341232]
27. Noventa M, Gizzo S, Saccardi C, et al. Salpingectomy before assisted reproductive technologies: a systematic literature review // J Ovarian Res. 2016;9(№1):74. Published 2016. [PMID: 27809927]
28. Vitagliano A., Saccardi C., Noventa M. et al. Effects of chronic endometritis therapy on in vitro fertilization outcome in women with repeated implantation failure: a systematic review and meta-analysis // Fertil. Steril. 2018. Vol. 110. №1. P. 103–112.e1. [PMID: 29908776]
29. McQueen D.B., Perfetto C.O., Hazard F.K., Lathi R.B. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss // Fertil. Steril. 2015. Vol. 104.№4. P. 927–931. [PMID: 26207958]
30. Mikhaleva L.M., Boltovskaya M.N., Mikhalev S.A. et al. Kliniko-morfologicheskie aspekty éndometrial’noĭ disfunktsii, obuslovlennoĭ khronicheskim éndometritom [Endometrial dysfunction caused by chronic endometritis: сlinical and morphological aspects] // Arkh Patol. 2017. Vol. 79. №6. P. 22–29. [PMID: 29265074]
31. Liu Y, Chen X, Huang J, et al. Comparison of the prevalence of chronic endometritis as determined by means of different diagnostic methods in women with and without reproductive failure [published correction appears in Fertil Steril. 2019 Feb;111(2):411] // Fertil Steril. 2018;109(№5):832–839. [PMID: 29778382]
32. Kitaya K., Matsubayashi H., Takaya Y. et al. Live birth rate following oral antibiotic treatment for chronic endometritis in infertile women with repeated implantation failure // Am. J. Reprod. Immunol. 2017. Vol. 78. №5. P. 10.1111/aji.12719. [PMID: 28608596]
33. Sfakianoudis K., Simopoulou M., Nikas Y. et al. Efficient treatment of chronic endometritis through a novel approach of intrauterine antibiotic infusion: a case series // BMC Womens Health. 2018. Vol. 18. №1. P. 197. Published 2018 [PMID: 30518370]
34. Cicinelli E., Matteo M., Tinelli R. et al. Prevalence of chronic endometritis in repeated unexplained implantation failure and the IVF success rate after antibiotic therapy // Hum Reprod. 2015. Vol. 30. №2. P. 323–330. [PMID: 25385744]
35. Cicinelli E., Matteo M., Trojano G. et al. Chronic endometritis in patients with unexplained infertility: Prevalence and effects of antibiotic treatment on spontaneous conception // Am. J. Reprod. Immunol. 2018. Vol. 79. №1. P. 10.1111/aji.12782. [PMID: 29135053]
36. Sfakianoudis K., Simopoulou M., Nitsos N. et al. Successful Implantation and Live Birth Following Autologous Platelet-rich Plasma Treatment for a Patient with Recurrent Implantation Failure and Chronic Endometritis // In Vivo. 2019. Vol. 33. №2. P. 515–521. [PMID: 30804135]
37. Kovaleva Y.V. Primenenie nizkochastotnogo ul’trazvuka v kompleksnoĭ terapii i reabilitatsii patsientok s khronicheskim éndometritom [The application of low-frequency ultrasound for the comprehensive treatment and rehabilitation of the patients presenting with chronic endometritis] // Vopr. Kurortol. Fizioter. Lech Fiz. Kult. 2017. Vol. 94. №3. P. 32–38. [PMID: 28884736
38. Skoropatskaya O.A., Remneva O.B., Yavorskaya S.D., Levchenko I.M. Pregravidarnaia podgotovka patsientok s khronicheskim éndometritom: otsenka éffektivnosti fito- i fizioterapii [The preconceptional preparation of the patients presenting with chronic endometritis: the evaluation of the effectiveness of phyto- and physiotherapy // Vopr. Kurortol. Fizioter. Lech Fiz. Kult. 2018. Vol. 95. №4. P. 41–47. [PMID: 30168513]
39. Реабилитация эндометрия после потери беременности // Гинекология. 2009. Т. 11. №4. С. 55–58.
40. Деликатному эндометрию деликатный подход. Сложные вопросы использования эстрогенов в репродуктивном возрасте // StatusPraesens. Гинекология, акушерство, бесплодный брак. 2014. №4 (21). С. 55–60.
41. Доброкачественные и предраковые заболевания шейки матки с позиции профилактики рака: Клинические рекомендации. М., 2017. С. 53.
42. Pandey D., Solleti V., Jain G. et al. Human Papillomavirus (HPV) Infection in Early Pregnancy: Prevalence and Implications // Infect Dis Obstet. Gynecol. 2019. Vol. 2019. P. 4376902. [Published 2019] [PMID: 31019362]
43. Xiong Y.Q., Mo Y., Luo Q.M. et al. The Risk of Human Papillomavirus Infection for Spontaneous Abortion, Spontaneous Preterm Birth, and Pregnancy Rate of Assisted Reproductive Technologies: A Systematic Review and Meta-Analysis // Gynecol. Obstet. Invest. 2018. Vol. 83. №5. P. 417–427. [PMID: 29649818]
44. Миома матки: диагностика, лечение и реабилитация: Клинические рекомендации. М., 2015. С. 49.
45. Sogc clinical practice guideline. The Management of Uterine Leiomyomas // J. Obstet. Gynaecol. Can. 2015. Vol. 37. №2. P. 157–178. — https://www.jogc.com/article/S1701-2163(15)30338-8/pdf.
46. Karlsen K., Hrobjartsson A., Korsholm M. et al. Fertility after uterine artery embolization of fibroids: a systematic review // Arch Gynecol. Obstet. 2018. Vol. 297. №1. P. 13–25. [PMID: 29052017]
47. URL: https://ovarianresearch.biomedcentral.com/articles/10.1186/s13048-018-0420-1.
48. Pritts EA. Fibroids and infertility: a systematic review of the evidence // Obstet Gynecol Surv. 2001;56(№8):483–491 [PMID: 11496160]
49. Pritts E.A., Parker W.H., Olive D.L. Fibroids and infertility: an updated systematic review of the evidence // Fertil. Steril. 2009. Vol. 91. №4. P. 1215–1223. [PMID: 18339376]
50. Ahdad-Yata N., Fernandez H., Nazac A. et al. Fertilité après résection hystéroscopique de myomes sous-muqueux chez des patientes infertiles [Fertility after hysteroscopic resection of submucosal myoma in infertile women] // J. Gynecol. Obstet. Biol. Reprod. (Paris). 2016. Vol. 45. №6. P. 563–570. [PMID: 26321611]
51. Metwally M., Farquhar C.M., Li T.C. Is another meta-analysis on the effects of intramural fibroids on reproductive outcomes needed? // Reprod. Biomed Online. 2011. Vol. 23. №1. P. 2–14. [PMID: 21549642]
52. Эндометриоз: Российские клинические рекомендации. М., 2016. — URL: https://spnavigator.ru/document/6a12b701-cc27-4708-abc5-89299e770bbc.
53. Johnson N.P., Hummelshoj L; World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis // Hum. Reprod. 2013. Vol. 28. №6. P. 1552–1568. [PMID: 23528916]
54. Dunselman G.A., Vermeulen N., Becker C. et al. ESHRE guideline: management of women with endometriosis // Hum. Reprod. 2014. Vol. 29. №3. P. 400–412. [PMID: 24435778]
55. Saridogan E., Becker C.M. et al.; Working group of ESGE, ESHRE, and WES. Recommendations for the surgical treatment of endometriosis-part 1: ovarian endometrioma // Gynecol Surg. 2017. Vol. 14. №1. P. 27. [PMID: 29285022]
56. Keckstein J., Becker C.M. et al.; Working group of ESGE, ESHRE, and WES. Recommendations for the surgical treatment of endometriosis. Part 2: deep endometriosis // Hum. Reprod. Open. 2020. Vol. 2020. №1. P. hoaa002. [PMID: 32064361]
57. Endometriosis: diagnosis and management. 2017. — URL: https://www.nice.org.uk/guidance/ng73.
58. Hughes E., Brown J., Collins J.J. et al. Ovulation suppression for endometriosis // Cochrane Database Syst. Rev. 2007. Vol. 3. Art. №CD000155. [PMID: 17636607]
59. Sallam H.N., Garcia-Velasco J.A., Dias S., Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis // Cochrane Database Syst. Rev. 2006. Vol. 1. Art. №CD004635. [PMID: 16437491]
60. Duffy J.M., Arambage K., Correa F.J. et al. Laparoscopic surgery for endometriosis // Cochrane Database Syst. Rev. 2014. Vol. 4. Art. №CD011031. [PMID: 24696265]
61. Alborzi S., Zahiri Sorouri Z., Askari E. et al. The success of various endometrioma treatments in infertility: A systematic review and meta-analysis of prospective studies // Reprod. Med. Biol. 2019. Vol. 18. №4. P. 312–322. [Published 2019] [PMID: 31607791]
62. Brown J., Farquhar C. Endometriosis: an overview of Cochrane Reviews. Cochrane Database Syst Rev. 2014. Vol. 3. Art. №CD009590. [Published 2014] [PMID: 24610050]
63. Hwang H., Chung Y.J., Lee S.R. et al. Clinical evaluation and management of endometriosis: guideline for Korean patients from Korean Society of Endometriosis // Obstet. Gynecol. Sci. 2018. Sep. Vol. 61. №5. P. 553–564.
64. Hart R.J., Hickey M., Maouris P., Buckett W. Excisional surgery versus ablative surgery for ovarian endometriomata // Cochrane Database Syst. Rev. 2008. Vol. 2. Art. №CD004992. [PMID: 18425908]
65. Yap C., Furness S., Farquhar C. Pre and post operative medical therapy for endometriosis surgery // Cochrane Database Syst. Rev. 2004. Vol. 3. Art. №CD003678. [PMID: 15266496]
66. Somigliana E., Garcia-Velasco J.A. Treatment of infertility associated with deep endometriosis: definition of therapeutic balances // Fertil. Steril. 2015. Vol. 104. №4. P. 764–770. [PMID: 26342244]
67. Benaglia L., Cardellicchio L., Leonardi M. et al. Asymptomatic adenomyosis and embryo implantation in IVF cycles // Reprod Biomed Online. 2014. Vol. 29. №5. P. 606–611. [PMID: 25246118]
68. Синдром поликистозных яичников в репродуктивном возрасте (современные подходы к диагностике и лечению): Клинические рекомендации. М., 2015. С. 22.
69. Женское бесплодие (современные подходы к диагностике и лечению): Клинические рекомендации М., 2019.
70. Goodman N.F., Cobin R.H., Futterweit W. et al. American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome. Part 2 // Endocr. Pract. 2015. Vol. 21. №12. P. 1415–1426. [PMID: 26642102]
71. Qi Q. et al. Association of methylenetetrahydrofolate reductase gene polymorphisms with polycystic ovary syndrome // Chin. J. Med. Genet. 2015. Vol. 32. №3. P. 400–404. [PMID: 26037361]
72. Chakraborty P., Goswami S.K., Rajani S. et al. Recurrent pregnancy loss in polycystic ovary syndrome: Role of hyperhomocysteinemia and insulin resistance // PLoS One. 2013. Vol. 8. Р. e64446. [PMID: 23700477]
73. Balen A.H., Morley L.C., Misso M. et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance // Hum. Reprod. Update. 2016. Vol. 22. №6. P. 687–708. [PMID: 27511809]
74. Morgante G., Cappelli V., Troìa L., De Leo V. Evaluation of different antiandrogenic progestins on clinical and biochemical variables in polycystic ovary syndrome // Eur. J. Contracept. Reprod. Health Care. 2020. Vol. 25. №3. P. 176–181. [PMID: 32191532]
75. Asemi Z., Karamali M., Esmaillzadeh A. Metabolic response to folate supplementation in overweight women with polycystic ovary syndrome: a randomized double-blind placebo-controlled clinical trial // Mol. Nutr. Food Res. 2014. Vol. 58. №7. P. 1465–1473. [PMID: 24828019]
76. Дефицит витамина D у взрослых: Клинические рекомендации. М.,2016. С.39. — URL: https://rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdf.
77. Melo A.S., Ferriani R.A., Navarro P.A. Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice // Clinics (Sao Paulo). 2015. Vol. 70. №11. P. 765–769. [PMID: 26602525]
78. Очерки эндокринной гинекологии / В.Е. Радзинский, М.Б. Хамошина, О.А. Раевская и др.; под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2020. 576 с.
79. RCOG Green-top Guideline No. 45, Oct. 2015. — URL: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg45/.
80. Osser O.V., Jokubkiene L., Valentin L. Cesarean section scar defects: agreement between transvaginal sonographic findings with and without saline contrast enhancement // Ultrasound Obstet. Gynecol. 2010. Vol. 35. №1. P. 75. [PMID: 20034000]
81. Vikhareva Osser O., Valentin L. Clinical importance of appearance of cesarean hysterotomy scar at transvaginal ultrasonography in nonpregnant women // Obstet. Gynecol. 2011. Vol. 117. №3. P. 525. [PMID: 21343754]
82. Schepker N., Garcia-Rocha G.J., Von Versen-Höynck F. et al. Clinical diagnosis and therapy of uterine scar defects after caesarean section in non-pregnant women // Arch Gynecol. Obstet. 2015. Jun. Vol. 291. №6. P. 1417–1423. [PMID: 25516174]
83. Klemm P., Koehler C., Mangler M. et al. Laparoscopic and vaginal repair of uterine scar dehiscence following cesarean section as detected by ultrasound // J. Perinat. Med. 2005. Vol. 33. №4. P. 324. [PMID: 16207118]
84. Donnez O., Jadoul P., Squifflet J., Donnez J. Laparoscopic repair of wide and deep uterine scar dehiscence after cesarean section // Fertil. Steril. 2008. Vol. 89. №4. P. 974 [PMID: 17624346]
85. Landon M.B, Uterine rupture: After previous cesarean delivery, UpToDate, Jul. 2020.
1. ВОЗ. Ожирение и избыточный вес. — URL: https://www.who.int/ru/news-room/fact-sheets/detail/obesity-and-overweight.
2. Schummers L., Hutcheon J.A., Bodnar L.M. et al. Risk of adverse pregnancy outcomes by prepregnancy body mass index: a population-based study to inform prepregnancy weight loss counseling // Obstet. Gynecol. 2015. Vol. 125. №1. P. 133–143. [PMID: 25560115]
3. Abell S., Nankervis A., Kha, K., Teede H. Type 1 and Type 2. Diabetes Preconception and in Pregnancy: Health Impacts, Influence of Obesity and Lifestyle, and Principles of Management // Seminars in Reproductive Medicine. 2016. Vol. 34. №02. P. 110–120. [PMID: 26854707]
4. Celik C., Tasdemir N., Abali R. et al. Progression to impaired glucose tolerance or type 2 diabetes mellitus in polycystic ovary syndrome: a controlled follow-up study // Fertil. Steril. 2014. Vol. 101. №4. P. 1123–8.e1. [PMID: 2450289]
5. Ng N.Y.H., Jiang G., Cheung L.P. et al. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study // PLoS Med. 2019. Vol. 16. №10. P. e1002953. [PMID: 31652273]
6. Rafiq S., Jeppesen P.B. Body Mass Index, Vitamin D, and Type 2 Diabetes: A Systematic Review and Meta-Analysis // Nutrients. 2018. Vol. 10. №9. P. 1182. [Published 2018 Aug 28] [PMID: 30154381]
7. Дефицит витамина D у взрослых: Клинические рекомендации. М., 2016. С. 39. — URL: https://rae-org.ru/system/files/documents/pdf/kr342_deficit_vitamina_d_u_vzroslyh.pdf.
8. Лечение морбидного ожирения у взрослых: Клинические рекомендации. М., 2016. С. 39. — URL: https://www.endocrincentr.ru/sites/default/files/specialists/science/clinic-recomendations/klin_rek_mo-_
2016.pdf.
9. Peirson L., Douketis J., Ciliska D. et al. Treatment for overweight and obesity in adult populations: a systematic review and meta-analysis // CMAJ Open. 2014. Vol. 2. №4. P. E306–E317. [PMID: 25485258]
10. Best D., Avenell A., Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence // Hum. Reprod Update. 2017. Vol. 23. №6. P. 681–705. [PMID: 28961722]
11. Khera R., Murad M.H., Chandar A.K. et al. Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis // JAMA. 2016. Sep 6. Vol. 316. №9. P. 995. [PMID: 27299618]
12. O’Brien P.E., Hindle A., Brennan L. et al. Long-Term Outcomes After Bariatric Surgery: a Systematic Review and Meta-analysis of Weight Loss at 10 or More Years for All Bariatric Procedures and a Single-Centre Review of 20-Year Outcomes After Adjustable Gastric Banding // Obes. Surg. 2019. [PMID: 30293134]
13. Lentferink Y.E., Knibbe C.A.J., Van der Vorst MMJ. Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review // Drugs. 2018. Vol. 78. №18. P. 1887–1901. [PMID: 30511324]
14. Ning H.H., Le J., Wang Q. et al. The effects of metformin on simple obesity: a meta-analysis // Endocrine. 2018. Vol. 62. №3. P. 528–534. [PMID: 30151735]
15. FIGO committee reports «Best practice in maternal–fetal medicine». — URL: https://obgyn.onlinelibrary.wiley.com/doi/abs/10.1016/j.ijgo.2014.10.011.
16. O’Malley E.G., Reynolds C.M.E., Cawley S. et al. Folate and vitamin B12 levels in early pregnancy and maternal obesity // Eur. J. Obstet. Gynecol. Reprod. Biol. 2018. Vol. 231. P. 80–84. [PMID: 30336308]
17. Gao L.J., Wang Z.P., Lu Q.B. et al. Maternal overweight and obesity and the risk of neural tube defects: a case-control study in China // Birth. Defects. Res. A. Clin. Mol. Teratol. 2013. Vol. 97. №3. P. 161–165. [PMID: 23483719]
18. Planning for Pregnancy. — URL: https://ranzcog.edu.au/womens-health/patient-information-resources/planning-for-pregnancy.
19. Cefalo C.M.A., Conte C., Sorice G.P. et al. Effect of Vitamin D Supplementation on Obesity-Induced Insulin Resistance: A Double-Blind, Randomized, Placebo-Controlled Trial // Obesity (Silver Spring). 2018. Vol. 26.№4. P. 651–657. [PMID: 29504254]
20. Subih H.S., Zueter Z., Obeidat B.M. et al. A high weekly dose of cholecalciferol and calcium supplement enhances weight loss and improves health biomarkers in obese women // Nutr. Res. 2018. Vol. 59. P. 53–64. [PMID: 30442233]
21. Сахарный диабет 2-го типа у взрослых: Клинические рекомендации. М., 2019. С. 228. — URL: https://rae-org.ru/system/files/documents/pdf/saharnyy_diabet_2_tipa_u_vzroslyh.pdf.
22. Gutaj P., Zawiejska A., Wender-Ożegowska E., Brązert J. Maternal factors predictive of first-trimester pregnancy loss in women with pregestational diabetes // Pol. Arch. Med. Wewn. 2013. Vol. 123. №1–2. P. 21–28. [PMID: 23302725]
23. Mackin S.T., Nelson S.M., Wild S.H. et al. Factors associated with stillbirth in women with diabetes // Diabetologia. 2019. Vol. 62. №10. P. 1938–1947. [PMID: 31353418]
24. Morikawa M., Kato-Hirayama E., Mayama M. et al. Glycemic control and fetal growth of women with diabetes mellitus and subsequent hypertensive disorders of pregnancy // PLoS One. 2020. Vol. 15. №3. P. e0230488. [PMID: 32176740]
25. Алгоритмы специализированной медицинской помощи больным сахарным диабетом: Клинические рекомендации. 7-1 вып. / Под ред. И.И Дедова, М.В. Шестаковой // Сахарный диабет. 2015. №18. С. 1–112.
26. American Diabetes Association. 13. Management of Diabetes in Pregnancy // Diabetes Care. 2017. Vol. 40. Suppl. 1. P. S114–S119. [PMID: 27979900]
27. Ekpebegh C.O., Coetzee E.J., Van der Merwe L., Levitt N.S. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents // Diabet Med. 2007. Vol. 24. №3. P. 253–258. [PMID: 17305787]
28. National Collaborating Centre for Women’s and Children’s Health (UK). Diabetes in Pregnancy: Management of Diabetes and Its Complications from Preconception to the Postnatal Period. London: National Institute for Health and Care Excellence (UK). February 2015. [PMID: 25950069]
29. Mahmud M., Mazza D. Preconception care of women with diabetes: a review of current guideline recommendations // BMC Women’s Health. 2010. Vol. 10. P. 5. — URL: https://doi.org/10.1186/1472-6874-10-5.
30. Macintosh M.C., Fleming K.M., Bailey J.A. et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: population based study // BMJ. 2006. Vol. 333. №7560. P. 177. [PMID: 16782722]
31. WHO. Periconceptional daily folic acid (400 µg) supplementation for prevention of neural tube defects. — URL: https://www.who.int/selection_medicines/committees/expert/20/applications/Folic_acid.pdf.
32. Alexander E.K., Pearce E.N., Brent G.A. et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum [published correction appears in Thyroid. 2017 Sep;27(№9):1212] // Thyroid. 2017. Vol. 27. №3. P. 315–389. [PMID: 28056690]
33. Платонова Н.М. Гипотиреоз и беременность // Поликлиника. 2014. №2. С. 1–5.
34. King J.R., Lachica R., Lee R.H. et al. Diagnosis and Management of Hyperthyroidism in Pregnancy: A Review // Obstet. Gynecol. Surv. 2016. Vol. 71. №11. P. 675–685. [PMID: 27901552]
35. Эндокринология. Российские клинические рекомендации / Под ред. И.И. Дедова, Г.А. Мелбниченко. М.: ГЭОТАР-Медиа, 2016. 598 с.
36. Shinohara D.R., Santos T.D.S., De Carvalho H.C. et al. Pregnancy Complications Associated With Maternal Hypothyroidism: A Systematic Review // Obstet. Gynecol. Surv. 2018. Vol. 73. №4. P. 219–230. [PMID: 29701867]
37. Беременность ранних сроков. От прегравидарной подготовки к здоровой гестации / Под ред. В.Е. Радзинского, А.А. Оразмурадова. 3-е изд. М.: Редакция журнала StatusPraesens, 2018. 800 с.
38. Yassa L., Marqusee E., Fawcett R., Alexander E.K. Thyroid hormone early adjustment in pregnancy (the THERAPY) trial // J. Clin. Endocrinol. Metab. 2010. Vol. 95. №7. P. 3234–3241. [PMID: 20463094]
39. Sullivan S.D., Downs E., Popoveniuc G. et al. Randomized Trial Comparing Two Algorithms for Levothyroxine Dose Adjustment in Pregnant Women With Primary Hypothyroidism // J. Clin. Endocrinol. Metab. 2017. Vol. 102. №9. P. 3499–3507. [PMID: 28911144]
40. Женская консультация: Руководство / Под ред. В.Е. Радзинского. 3-е изд. М.: ГЭОТАР-Медиа, 2009. 472 с.
41. Andersen S.L., Olsen J., Laurberg P. Antithyroid Drug Side Effects in the Population and in Pregnancy // J. Clin. Endocrinol. Metab. 2016. Vol. 101. №4. P. 1606–1614. [PMID: 26815881]
42. Andersen S.L., Olsen J., Wu C.S., Laurberg P. Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study // J. Clin. Endocrinol. Metab. 2013. Vol. 98. №11. P. 4373–4381. [PMID: 24151287]
43. Очерки эндокринной гинекологии / В.Е. Радзинский, М.Б. Хамошина, О.А. Раевская и др.; под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2020. 576 с.
44. Клиническая фармакология. Акушерство. Гинекология. Бесплодный брак / Под ред. В.Е. Радзинского, Р.Н. Аляутдина. М.: ГЭОТАР-Медиа, 2016. 672 с.
45. Гиперпролактинемия: Клинические рекомендации. М., 2016. С. 30. — URL: https://rae-org.ru/system/files/documents/pdf/kr85_giperprolaktinemiya.pdf.
46. Жукова Э.В., Романцова Т.И., Дзеранова Л.К. и др. Особенности течения беременности и родов у больных с синдромом гиперпролактинемии. — URL: http://www.voed.ru/giperprolakt_sindr_berem.htm.
47. Melmed S., Casanueva F., Hoffman A. et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society Clinical Practice Guideline // J. Clin. Endocrinol. Metab. 2011. Vol. 96. P. 273–288. [PMID: 21296991]
48. Hu Y., Ding Y., Yang M., Xiang Z. Serum prolactin levels across pregnancy and the establishment of reference intervals // Clin. Chem. Lab Med. 2018. Vol. 56. №5. P. 803–880. [PMID: 29194037]
49. Pacchiarotti I., Murru A., Kotzalidis G.D. et al. Hyperprolactinemia and medications for bipolar disorder: systematic review of a neglected issue in clinical practice // Eur. Neuropsychopharmacol. 2015. Vol. 25. №8. P. 1045–1059. [PMID: 25937241]
50. Soto-Pedre E., Newey P.J., Bevan J.S. et al. The epidemiology of hyperprolactinaemia over 20 years in the Tayside region of Scotland: the Prolactin Epidemiology, Audit and Research Study (PROLEARS) // Clin. Endocrinol. (Oxf). 2017. Vol. 86. №1. P. 60–67. [PMID: 27434534]
51. Sharma L.K., Sharma N., Gadpayle A.K., Dutta D. Prevalence and predictors of hyperprolactinemia in subclinical hypothyroidism // Eur. J. Intern Med. 2016. Vol. 35. P. 106–110. [PMID: 27473607]
52. Goel P. et al. Evaluation of serum prolactin level in patients of subclinical and overt hypothyroidism // J. Clin. Diagn. Res. 2015. Vol. 9. №1. P. BC15–BC17. [PMID: 25737975]
53. Donadio F., Barbieri A., Angioni R. et al. Patients with macroprolactinaemia: clinical and radiological features // Eur. J. Clin. Invest. 2007. Vol. 37. №7. P. 552–557. [PMID: 17576206]
54. Beda-Maluga K., Pisarek H., Komorowski J. et al. The detection of macroprolactin by precipitation and ultrafiltration methods // Endokrynol Pol. 2011. Vol. 62. №6. P. 529–536. [PMID: 22144220]
55. Šostarić M., Bokulić A., Marijančević D., Zec I. Optimizing laboratory defined macroprolactin algorithm // Biochem. Med (Zagreb). 2019. Vol. 29. №2. P. 020706. [PMID: 31223260]
56. Wang A.T., Mullan R.J., Lane M.A. et al. Treatment of hyperprolactinemia: a systematic review and meta-analysis // Syst. Rev. 2012. Vol. 1. P. 33. [PMID: 22828169]
57. O’Sullivan S.M., Farrant M.T. et al. An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists // Aust. N. Z. J. Obstet. Gynaecol. 2020. Vol. 60. №3. P. 405–411. [PMID: 31583693]
58. Sant’ Anna B.G., Musolino N.R.C., Gadelha M.R. et al. A Brazilian multicentre study evaluating pregnancies induced by cabergoline in patients harboring prolactinomas // Pituitary. 2020. Vol. 23. №2. P. 120–128. [PMID: 31728906]
59. Casanueva F.F., Molitch M.E., Schlechte J.A. et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas // Clin. Endocrinol. (Oxf). 2006. Vol. 65. №2. P. 265–273. [PMID: 16886971]
60. Zamanipoor Najafabadi A.H., Zandbergen I.M., De Vries F. et al. Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis // J. Clin. Endocrinol. Metab. 2020. Vol. 105. №3. P. e32–e41. [PMID: 31665485]
61. Федеральные клинические рекомендации по диагностике и лечению железодефицитной анемии. М., 2014. 16 с.
62. Железодефицитные состояния у беременных и родильниц: Учебное пособие / Под ред. Г.Т. Сухих, Т.А. Протопоповой. М.: Системные решения, 2009. 80 с.
63. Horowitz K.M., Ingardia C.J., Borgida A.F. Anemia in pregnancy // Clin. Lab. Med. 2013. Vol. 33. №2. P. 281–291. [PMID: 23702118]
64. Gautam C.S., Saha L., Sekhri K., Saha P.K. Iron deficiency in pregnancy and the rationality of iron supplements prescribed during pregnancy // Medscape J. Med. 2008. Vol. 10. №12. P. 283. [PMID: 19242589]
65. Patra S., Pasrija S., Trivedi S.S., Puri M. Maternal and perinatal outcome in patients with severe anemia in pregnancy // Int. J. Gynaecol. Obstet. 2005. Vol. 91. №2. P. 164–165. [PMID: 16125707]
66. Стуклов Н.И. Проблема скрытых железодефицитных состояний у женщин репродуктивного возраста. — URL: https://spnavigator.ru/document/1ceedcf1-0102-4aa4-8c4b-cd4d9f881802#fn:4.
67. Breymann C., Honegger C., Hösli I., Surbek D. Diagnosis and treatment of iron-deficiency anaemia in pregnancy and postpartum // Arch Gynecol. Obstet. 2017. Vol. 296. №6. P. 1229–1234. [PMID: 28940095]
68. BC Guidelines. Iron Deficiency — Diagnosis and Management. — URL: https://www2.gov.bc.ca/gov/content/health/practitioner-professional-resources/bc-guidelines/iron-deficiency#oral-iron.
69. Хронический пиелонефрит у взрослых: Клинические рекомендации. М., 2016. — URL: https://medi.ru/klinicheskie-rekomendatsii/khronicheskij-pielonefrit-u-vzroslykh_14026/.
70. EAU Guidelines. Edn. presented at the EAU Annual Congress Amsterdam the Netherlands 2020. — URL: https://uroweb.org/guideline/urological-infections/#6.
71. Anger J., Lee U., Ackerman A.L., et al. Recurrent Uncomplicated Urinary Tract Infections in Women: AUA/CUA/SUFU Guideline // J. Urol. 2019. Vol. 202. №2. P. 282–289. [PMID: 31042112]
72. Farkash E., Weintraub A.Y., Sergienko R. et al. Acute antepartum pyelonephritis in pregnancy: a critical analysis of risk factors and outcomes // Eur. J. Obstet. Gynecol. Reprod. Biol. 2012. Vol. 162. №1. P. 24–27. [PMID: 22381037]
73. Kaduma J., Seni J., Chuma C. et al. Urinary Tract Infections and Preeclampsia among Pregnant Women Attending Two Hospitals in Mwanza City, Tanzania: A 1:2 Matched Case-Control Study // Biomed Res Int. 2019. [PMID: 31032344]
74. Юнусова Л.Н. и др. Эпидемиологические особенности заболевания хроническим пиелонефритом у женщин в период гестации // Современные проблемы науки и образования. 2015. №3. С. 106–106.
75. Lotan Y., Daudon M., Bruyère F. et al. Impact of fluid intake in the prevention of urinary system diseases: a brief review // Curr. Opin. Nephrol. Hypertens. 2013. Vol. 22. Suppl. 1. P. S1–S10. [PMID: 23673384]
76. Mantzorou M., Giaginis C. Cranberry Consumption Against Urinary Tract Infections: Clinical Stateof- the-Art and Future Perspectives // Curr. Pharm. Biotechnol. 2018. Vol. 19. №13. P. 1049–1063. [PMID: 30520372]
77. Falah F., Vasiee A., Behbahani B.A. et al. Evaluation of adherence and anti-infective properties of probiotic Lactobacillus fermentum strain 4-17 against Escherichia coli causing urinary tract infection in humans // Microb. Pathog. 2019. Vol. 131. P. 246–253 [PMID: 30974159]
78. Atassi F., Pho Viet Ahn D.L., Lievin-Le Moal V. Diverse Expression of Antimicrobial Activities Against Bacterial Vaginosis and Urinary Tract Infection Pathogens by Cervicovaginal Microbiota Strains of Lactobacillus gasseri and Lactobacillus crispatus // Front Microbiol. 2019. Vol. 10. P. 2900. [Published 2019] [PMID: 31921075]
79. Sumati A.H., Saritha N.K. Association of urinary tract infection in women with bacterial vaginosis // J. Glob. Infect. Dis. 2009. Vol. 1. №2. P. 151–152. [PMID: 20300409]
80. Nicolle L.E., Gupta K., Bradley S.F. et al. Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America // Clinical Infectious Diseases. 2019. 15 May. Vol. 68. №10. P. e83–e110.
81. Олина А.А., Галинова И.В. Современные особенности ведения беременных женщин с бессимптомной бактериурией в практике акушера-гинеколога // РМЖ. Медицинское обозрение. 2018. №12. С. 36–41.
82. Артериальная гипертония у беременных: Клинические рекомендации. М., 2016. С. 30.
83. Диагностика и лечение сердечно-сосудистых заболеваний при беременности: Национальные рекомендации. М., 2018. С. 44.
84. Jääskeläinen T., Heinonen S., Kajantie E. et al. Cohort profile: the Finnish Genetics of Pre-eclampsia Consortium (FINNPEC) // BMJ Open. 2016. Vol. 6. №11. P. e013148. [PMID: 28067621]
85. Atkins E.R., Rodgers A. More Versus Less Blood Pressure Lowering: An Update // Clin. Ther. 2016. Vol. 38. №10. P. 2135–2141. [PMID: 27633256]
86. Чазова И.Е., Жернакова Ю.В. от имени экспертов. Клинические рекомендации. Диагностика и лечение артериальной гипертонии // Системные гипертензии. 2019. №16 (1). С. 6–31.
87. Modified World Health Organization classification of maternal cardiovascular risk. — URL: https://academic.oup.com/view-large/186437995.
88. American Gastroenterological Association Medical Position Statement on Constipation. — URL: https://www.gastrojournal.org/article/S0016-5085(12)01545-4/fulltext#articleInformation.
89. Tantawy S.A., Kamel D.M., Abdelbasset W.K., Elgohary H.M. Effects of a proposed physical activity and diet control to manage constipation in middle-aged obese women // Diabetes Metab. Syndr. Obes. 2017. Vol. 10. P. 513–519. [Published 2017] [PMID: 29276399]
90. Shen Q., Zhu H., Jiang G., Liu X. Nurse-Led Self-Management Educational Intervention Improves Symptoms of Patients With Functional Constipation // West J. Nurs. Res. 2018. Vol. 40. №6. P. 874–888. [PMID: 28395593]
91. Saccone G., Berghella V., Sarno L. et al. Celiac disease and obstetric complications: a systematic review and metaanalysis // Am. J. Obstet. Gynecol. 2016. Vol. 214. №2. P. 225–234. [PMID: 26432464]
92. Парфёнов А.И., Быкова С.В., Сабельникова Е.А. и др. Всероссийский консенсус по диагностике и лечению целиакии у детей и взрослых // Терапевтический архив. 2017. №03. С. 94–107. — URL: https://www.mediasphera.ru/issues/terapevticheskij-arkhiv/2017/3/downloads. /ru/1004036602017031094.
93. Клинические рекомендации по диагностике и лечению фенилкетонурии и нарушений обмена тетрагидробиоптерина. М.: Академиздат, 2014. 70 с. — URL: https://med-gen.ru/docs/recomend-fenilketonuriya.pdf.
94. Narula N., Cooray M., Anglin R. et al. Impact of High-Dose Vitamin D3 Supplementation in Patients with Crohns Disease in Remission: A Pilot Randomized Double-Blind Controlled Study // Dig Dis Sci. 2017. Vol. 62. №2. P. 448–455. [PMID: 27975236]
95. ВИЧ-инфекция у взрослых: Клинические рекомендации. М., 2017. С. 65.
96. Uthman O.A., Nachega J.B., Anderson J. et al. Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis // Lancet HIV. 2017. Vol. 4. №1. P. e21–e30. [PMID: 27864000]
97. Anglemyer A., Rutherford G.W., Horvath T. et al. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples // Cochrane Database Syst. Rev. [PMID: 23633367]
98. О порядке использования вспомогательных репродуктивных технологий, противопоказаниях и ограничениях к их применению: Приказ Минздрава России от 30 августа 2012 года №107н (зарег. в Минюсте России 12 февраля 2013 года №27010; ред. от 1 февраля 2018 года).
99. Вспомогательные репродуктивные технологии и искусственная инсеминация: Клинические рекомендации. М., 2018. С. 170.
100. Клинические рекомендации Российской гастроэнтерологической ассоциации и Российского общества по изучению печени по диагностике и лечению взрослых больных гепатитом В. М., 2014. — URL: http://rsls.ru/files/HBV-Clinical-Guidelines-2014.pdf.
101. Хронический вирусный гепатит С у взрослых: Клинические рекомендации. М, 2018. С. 90.
102. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection // Journal of Hepatology. 2017. Vol. 67. P. 370–398.
103. Инструкция по медицинскому применению лекарственного препарата «Рибавирин-ЛИПИНТ». ГРЛС, 2015. — URL: http://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=70f3c526-aa21-4caa-933c-9be6863d8cdb&t=.
1. Выкидыш в ранние сроки беременности: диагностика и тактика ведения: Клинические рекомендации. — URL: https://spnavigator.ru/document/29064492-5ed8-4496-a582-1968e9bce450.
2. Вспомогательные репродуктивные технологии и искусственная инсеминация: Клинические рекомендации. М., 2018. С. 170.
3. Bender Atik R., Christiansen O.B., Elson J. et al. recurrent pregnancy loss: ESHRE guideline // Hum. Reprod. Open. 2018. Vol. 2018. №2. P. hoy004. [PMID: 31486805]
4. Evaluation and treatment of recurrent pregnancy loss: A committee opinion / Practice committee of the American society for reproductive medicine // Fertil. Steril. 2012. Vol. 98. №5. P. 1103–1111. [PMID: 22835448]
5. Recurrent pregnancy loss causes, controversies, and treatment / Ed. J.A. Howard. 3rd ed. Boca Raton: Carp. CRC press Taylor & Francis group. 300 p.
6. Беременность ранних сроков. От прегравидарной подготовки к здоровой гестации / Под ред. В.Е. Радзинского, А.А. Оразмурадова. 3-е изд. М.: Редакция журнала StatusPraesens, 2020. 800 c.
7. Домрачева Е.В., Асеева Е.А., Раевская О.А., Дьяконов С.А. Генетические исследования при невынашивании беременности // StatusPraesens. Гинекология, акушерство, бесплодный брак. 2018. №5. С. 121–124.
8. Гинтер Е.К., Пузырев В.П. Наследственные болезни: Национальное руководство. Краткое изд. М.: ГЭОТАР-Мед, 2017. 464 c.
9. Радзинский В.Е., Хамошина М.Б., Раевская О.А. и др. Очерки эндокринной гинекологии / Под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2020. 576 с.
10. Резников А.Г. Препараты прогестерона: фармакологические особенности, преимущества, клиническое применение // Практикующий врач. 2004. №3. С. 5.
11. Haas D.M., Hathaway T.J., Ramsey P.S. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology // Cochrane Database Syst. Rev. 2019. Vol. 11. Art. №CD003511. [PMID: 31745982]
12. Van der Linden M., Buckingham K., Farquhar C. et al. Luteal phase support for assisted reproduction cycles // Cochrane Database Syst. Rev. 2015. Vol. 7. Art. №CD009154. [PMID: 26148507]
13. Wahabi H.A., Fayed A.A., Esmaeil S.A., Al Zeidan R.A. Progestogen for treating threatened miscarriage // Cochrane Database Syst. Rev. 2011. Vol. 12. Art. №CD005943. [PMID: 22161393]
14. Симоновская X.Ю., Алеев И.А. Невынашивание беременности: доказательная база дидрогестерона. Новости доказательной медицины дидрогестерона по профилактике и лечению невынашивания беременности: Информационное письмо / Под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2015. 24 с.
15. Coomarasamy A., Devall A.J., Brosens J.J. et al. Micronized vaginal progesterone to prevent miscarriage: A critical evaluation of randomized evidence // Am. J. Obstet. Gynecol. 2020. Vol. 223. №2. P. 167–176. [PMID: 32008730]
16. Carp H. A systematic review of dydrogesterone for the treatment of recurrent miscarriage // Gynecol. Endocrinol. 2015. Vol. 31. №6. P. 422–430. [PMID: 25765519]
17. Carp H. A systematic review of dydrogesterone for the treatment of threatened miscarriage // Gynecol. Endocrinol. 2012. Vol. 28. №12. P. 983–990. [PMID: 22794306]
18. Siew J.Y.S., Allen J.C., Hui C.Y.Y. et al. The randomised controlled trial of micronised progesterone and dydrogesterone (TRoMaD) for threatened miscarriage // Eur. J. Obstet. Gynecol. Reprod. Biol. 2018. Vol. 228. P. 319–324. [PMID: 30077119]
19. Tournaye H., Sukhikh G.T., Kahler E., Griesinger G. A phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization // Hum. Reprod. 2017. Vol. 32. №5. P. 1019–1027. [PMID: 28333318]
20. Venetis C.A., Papadopoulos S.P., Campo R. et al. Clinical implications of congenital uterine anomalies: A meta-analysis of comparative studies // Reprod. Biomed. Online. 2014. Vol. 29. №6. P. 665–683. [PMID: 25444500]
21. Letterie G.S. Management of congenital uterine abnormalities // Reprod. Biomed. Online. 2011. Vol. 23. №1. P. 40–52. [PMID: 21652266]
22. Bhagavath B., Ellie G., Griffiths K.M. et al. Uterine malformations: An update of diagnosis, management, and outcomes // Obstet. Gynecol. Surv. 2017. Vol. 72. №6. P. 377–392. [PMID: 28661551]
23. Chen X., Liu P., Sheng Y. et al. The impact of unicornuate uterus on perinatal outcomes after IVF/ICSI cycles: A matched retrospective cohort study // J. Matern. Fetal. Neonatal. Med. 2019. Vol. 32. №15. P. 2469–2474. [PMID: 29649918]
24. Ассоциация ревматологов России. Федеральные клинические рекомендации по лечению Антифосфолипидного синдрома. М., 2013.
25. Miyakis S., Lockshin M.D., Atsumi T. et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) // J. Thromb. Haemost. 2006. Vol. 4. №2. P. 295–306. [PMID: 16420554]
26. Hamulyák E.N., Scheres L.J., Marijnen M.C. et al. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss // Cochrane Database Syst. Rev. 2020. Vol. 5. Art. №CD012852. [PMID: 32358837]
27. Диагностика и лечебно-профилактические мероприятия при врождённой дисфункции коры надпочечников у пациентов во взрослом возрасте: Клинические рекомендации. М., 2016. 28 с.
28. Эндокринология. Фармакотерапия без ошибок: Руководство для врачей / Под ред. И.И. Дедова, Г.А. Мельниченко. М.: У-ното, 2013. C. 546–548.
29. Соловьёва А.В., Лищук О.В. Для зачатия нужны двое. Что должен знать акушер-гинеколог о диагностике мужского бесплодия: Информационный бюллетень / Под ред. В.Е. Радзинского. М.: Редакция журнала StatusPraesens, 2019. 16 с.
30. Клинические рекомендации по диагностике и лечению заболеваний, сопровождающихся патологическими выделениями из половых путей женщин. М., 2019. 57 с.
31. Ibrahim Y., Johnstone E. The male contribution to recurrent pregnancy loss // Transl. Androl. Urol. 2018. Vol. 7. №3. P. S317–S327. [PMID: 30159238]
Добро пожаловать на мероприятие!